Kaufmann Michael C

Chief Executive Officer at CAH

Sold, on record
$41.9M
Dollars the filings state
Form 4 sales
14
Latest Jan 22, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CAHCARDINAL HEALTH INCChief Executive Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CAHPlan not stated
    Jul 1, 2011 2011

    Sold 10,143 shares at $45.95 ($466k)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 14% of holdings ($3.3M position)62,160 shares left1.1x usual sizeFiling

  2. 2 Form 4 sale CAHUnusual
    Oct 27, 2011 +118 days

    Sold 43,164 shares at $44.95 ($1.9M)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 32.3% of holdings ($6M position)90,646 shares left4.3x usual sizeFiling

  3. 3 Form 4 sale CAHUnusual
    Jan 23, 2013 +454 days

    Sold 58,362 shares at $44.95 ($2.6M)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 35.9% of holdings ($7.3M position)104,330 shares left5.8x usual sizeFiling

  4. 4 Form 4 sale CAHUnusual
    May 22, 2013 +119 days

    Sold 36 shares at $47.52 ($2k)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 100% of holdings ($2k position)0 shares left0x usual sizeFiling

  5. 5 Form 4 sale CAHUnusual
    Feb 11, 2014 +265 days

    Sold 388,995 shares at $67.46 ($26.2M)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 77% of holdings ($34.1M position)115,969 shares leftFiling

  6. 6 Form 4 sale CAHPlan not stated
    Aug 18, 2014 +188 days

    Sold 6,833 shares at $72.06 ($492k)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 5.4% of holdings ($9M position)118,576 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale CAHUnusual
    Sep 4, 2014 +17 days

    Sold 50,216 shares at $74.95 ($3.8M)

    Kaufmann Michael C, CEO, Pharmaceutical Segment

    Sold 29.8% of holdings ($12.7M position)118,576 shares left1.5x usual sizeFiling

  8. 8 Form 4 sale CAHPlan not stated
    Jan 22, 2018 +1236 days

    Sold 18,586 shares at $73.90 ($1.4M)

    Kaufmann Michael C, Chief Executive Officer

    Sold 8.1% of holdings ($17M position)211,849 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Kaufmann Michael C
Source
Jan 22, 2018Jan 23, 2018CAHChief Executive OfficerForm 4 sale18,586$1.4M8.1%Plan not statedSEC
Sep 4, 2014Sep 5, 2014CAHCEO, Pharmaceutical SegmentForm 4 sale50,216$3.8M29.8%UnusualSEC
Aug 18, 2014Aug 19, 2014CAHCEO, Pharmaceutical SegmentForm 4 sale6,833$492k5.4%Plan not statedSEC
Feb 11, 2014Feb 11, 2014CAHCEO, Pharmaceutical SegmentForm 4 sale388,995$26.2M77.0%UnusualSEC
May 22, 2013May 23, 2013CAHCEO, Pharmaceutical SegmentForm 4 sale36$2k100.0%UnusualSEC
Jan 23, 2013Jan 25, 2013CAHCEO, Pharmaceutical SegmentForm 4 sale58,362$2.6M35.9%UnusualSEC
Oct 27, 2011Oct 28, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale43,164$1.9M32.3%UnusualSEC
Jul 1, 2011Jul 5, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale10,143$466k14.0%Plan not statedSEC
May 5, 2011May 9, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale10,143$456k14.0%Plan not statedSEC
Apr 27, 2011Apr 27, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale10,143$446k14.0%Plan not statedSEC
Apr 21, 2011Apr 25, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale8,560$368k12.1%UnusualSEC
Mar 18, 2011Mar 21, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale177$7k0.2%Plan not statedSEC
Feb 7, 2011Feb 8, 2011CAHCEO, Pharmaceutical SegmentForm 4 sale87,544$3.7M55.3%UnusualSEC
Dec 3, 2010Dec 7, 2010CAHCEO, Pharmaceutical SegmentForm 4 sale633$24k100.0%UnusualSEC